These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32753897)

  • 1. ARPP-19 Mediates Herceptin Resistance via Regulation of CD44 in Gastric Cancer.
    Gao X; Lu C; Chen C; Sun K; Liang Q; Shuai J; Wang X; Xu Y
    Onco Targets Ther; 2020; 13():6629-6643. PubMed ID: 32753897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CMIP promotes Herceptin resistance of HER2 positive gastric cancer cells.
    Xiang R; Han X; Ding K; Wu Z
    Pathol Res Pract; 2020 Feb; 216(2):152776. PubMed ID: 31822364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between HER-2/neu(erbB-2) expression level and therapeutic effect of combination treatment with HERCEPTIN and chemotherapeutic agents in gastric cancer cell lines.
    Cui H; Cheng Y; Piao SZ; Xu YJ; Sun HH; Cui X; Li XZ; Zhang SN; Piao LZ; Jin YM; Lin ZH; Shen XH
    Cancer Cell Int; 2014 Jan; 14(1):10. PubMed ID: 24472145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyethylene glycol-conjugated HER2-targeted peptides as a nuclear imaging probe for HER2-overexpressed gastric cancer detection in vivo.
    Guan SS; Wu CT; Chiu CY; Luo TY; Wu JY; Liao TZ; Liu SH
    J Transl Med; 2018 Jun; 16(1):168. PubMed ID: 29921305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HMGA2 regulates CD44 expression to promote gastric cancer cell motility and sphere formation.
    Sun J; Sun B; Zhu D; Zhao X; Zhang Y; Dong X; Che N; Li J; Liu F; Zhao N; Zhang D; Liu T; Lin X
    Am J Cancer Res; 2017; 7(2):260-274. PubMed ID: 28337375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D suppressed gastric cancer cell growth through downregulating CD44 expression in vitro and in vivo.
    Li Q; Li Y; Jiang H; Xiao Z; Wu X; Zhang H; Zhao Y; Du F; Chen Y; Wu Z; Li J; Hu W; Cho CH; Shen J; Li M
    Nutrition; 2021; 91-92():111413. PubMed ID: 34450383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. hsa_circ_0000520 influences herceptin resistance in gastric cancer cells through PI3K-Akt signaling pathway.
    Lv X; Li P; Wang J; Gao H; Hei Y; Zhang J; Li S
    J Clin Lab Anal; 2020 Oct; 34(10):e23449. PubMed ID: 32701211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-145 exerts tumor-suppressive and chemo-resistance lowering effects by targeting CD44 in gastric cancer.
    Zeng JF; Ma XQ; Wang LP; Wang W
    World J Gastroenterol; 2017 Apr; 23(13):2337-2345. PubMed ID: 28428713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apatinib exhibits synergistic effect with pyrotinib and reverses acquired pyrotinib resistance in HER2-positive gastric cancer via stem cell factor/c-kit signaling and its downstream pathways.
    Su B; Huang T; Jin Y; Yin H; Qiu H; Yuan X
    Gastric Cancer; 2021 Mar; 24(2):352-367. PubMed ID: 33030616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xiaotan Sanjie decoction attenuates tumor angiogenesis by manipulating Notch-1-regulated proliferation of gastric cancer stem-like cells.
    Yan B; Liu L; Zhao Y; Xiu LJ; Sun DZ; Liu X; Lu Y; Shi J; Zhang YC; Li YJ; Wang XW; Zhou YQ; Feng SH; Lv C; Wei PK; Qin ZF
    World J Gastroenterol; 2014 Sep; 20(36):13105-18. PubMed ID: 25278704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HER2 phosphorylation is maintained by a PKB negative feedback loop in response to anti-HER2 herceptin in breast cancer.
    Gijsen M; King P; Perera T; Parker PJ; Harris AL; Larijani B; Kong A
    PLoS Biol; 2010 Dec; 8(12):e1000563. PubMed ID: 21203579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Bcl-2 in Herceptin-Resistant Breast Cancer Cell Lines.
    Crawford A; Nahta R
    Curr Pharmacogenomics Person Med; 2011 Sep; 9(3):184-190. PubMed ID: 22162984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Darpp-32 and its truncated variant t-Darpp have antagonistic effects on breast cancer cell growth and herceptin resistance.
    Gu L; Waliany S; Kane SE
    PLoS One; 2009 Jul; 4(7):e6220. PubMed ID: 19593441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HER2-associated radioresistance of breast cancer stem cells isolated from HER2-negative breast cancer cells.
    Duru N; Fan M; Candas D; Menaa C; Liu HC; Nantajit D; Wen Y; Xiao K; Eldridge A; Chromy BA; Li S; Spitz DR; Lam KS; Wicha MS; Li JJ
    Clin Cancer Res; 2012 Dec; 18(24):6634-47. PubMed ID: 23091114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LMO4 mediates trastuzumab resistance in HER2 positive breast cancer cells.
    Ding K; Wu Z; Li X; Sheng Y; Wang X; Tan S
    Am J Cancer Res; 2018; 8(4):594-609. PubMed ID: 29736306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulated HSP27 in human breast cancer cells reduces Herceptin susceptibility by increasing Her2 protein stability.
    Kang SH; Kang KW; Kim KH; Kwon B; Kim SK; Lee HY; Kong SY; Lee ES; Jang SG; Yoo BC
    BMC Cancer; 2008 Oct; 8():286. PubMed ID: 18834540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel asymmetrical anti-HER2/CD3 bispecific antibody exhibits potent cytotoxicity for HER2-positive tumor cells.
    Yu S; Zhang J; Yan Y; Yao X; Fang L; Xiong H; Liu Y; Chu Q; Zhou P; Wu K
    J Exp Clin Cancer Res; 2019 Aug; 38(1):355. PubMed ID: 31412896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits.
    Chung SS; Giehl N; Wu Y; Vadgama JV
    Int J Oncol; 2014 Feb; 44(2):403-11. PubMed ID: 24297508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic emergence of the mesenchymal CD44(pos)CD24(neg/low) phenotype in HER2-gene amplified breast cancer cells with de novo resistance to trastuzumab (Herceptin).
    Oliveras-Ferraros C; Vazquez-Martin A; Martin-Castillo B; Cufí S; Del Barco S; Lopez-Bonet E; Brunet J; Menendez JA
    Biochem Biophys Res Commun; 2010 Jun; 397(1):27-33. PubMed ID: 20470755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RETRACTED: CD44 expression denotes a subpopulation of gastric cancer cells in which Hedgehog signaling promotes chemotherapy resistance.
    Yoon C; Park DJ; Schmidt B; Thomas NJ; Lee HJ; Kim TS; Janjigian YY; Cohen DJ; Yoon SS
    Clin Cancer Res; 2014 Aug; 20(15):3974-88. PubMed ID: 24947926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.